{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:54Z","timestamp":1790996754488,"version":"4.1.0"},"reference-count":95,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is considered to be the second most prominent neurodegenerative disease and has a global prevalence. Glucocerebrosidase (GBA1) gene mutations represent a significant hereditary risk factor for the development of PD and have a profound impact on the motor and cognitive progression of the disease. The aim of this review is to summarize the literature data on the prevalence, type, and peculiarities of GBA1 mutations in populations of different ethnic backgrounds. We reviewed articles spanning the 2000\u20132024 period. GBA1-related PD has a worldwide distribution. It has long been recognized that pathogenic GBA1 mutations are particularly common in certain ethnic populations, including PD patients of Ashkenazi Jewish ancestry. Moreover, a considerable number of studies focused on European ancestry patients from Europe and North America have revealed a high proportion (up to 15%) of carriers among the PD population. GBA1 mutations also appear to play an important role in patient groups with an East Asian background, although the frequency of specific variants may differ as compared to those of European ancestry. Notably, the assessment of underrepresented populations in other parts of Asia (including India) and Latin America is in the spotlight of current research, while a variant with a newly described pathogenic mechanism has been reported in Sub-Saharan Africans. Given the importance of GBA1 mutations for PD genetics and clinical phenotype, a focused assessment of the prevalence and type of GBA1 variants in distinct ethnic populations will possibly inform ongoing PD-related clinical studies and facilitate upcoming therapeutic trials.<\/jats:p>","DOI":"10.3390\/genes15121605","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T06:48:39Z","timestamp":1734331719000},"page":"1605","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A Global Perspective of GBA1-Related Parkinson\u2019s Disease: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5806-0717","authenticated-orcid":false,"given":"Christos","family":"Koros","sequence":"first","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-8711","authenticated-orcid":false,"given":"Anastasia","family":"Bougea","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Alefanti","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina Maria","family":"Simitsi","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-8472","authenticated-orcid":false,"given":"Nikolaos","family":"Papagiannakis","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Pachi","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-1145","authenticated-orcid":false,"given":"Evangelos","family":"Sfikas","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roubina","family":"Antonelou","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Paccosi, E., and Proietti-De-Santis, L. (2023). Parkinson\u2019s Disease: From Genetics and Epigenetics to Treatment, a MiRNA-Based Strategy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119547"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"107873","DOI":"10.1016\/j.pharmthera.2021.107873","article-title":"Oligonucleotides as Therapeutic Tools for Brain Disorders: Focus on Major Depressive Disorder and Parkinson\u2019s Disease","volume":"227","author":"Bortolozzi","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40035-024-00437-6","article-title":"Clinical, Mechanistic, Biomarker, and Therapeutic Advances in GBA1-Associated Parkinson\u2019s Disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher Disease with Parkinsonian Manifestations: Does Glucocerebrosidase Deficiency Contribute to a Vulnerability to Parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_6","first-page":"1353","article-title":"The Spectrum of Parkinsonian Manifestations Associated with Glucocerebrosidase Mutations","volume":"65","author":"Lopez","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson\u2019s Disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase Mutations in Clinical and Pathologically Proven Parkinson\u2019s Disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.parkreldis.2014.09.003","article-title":"Glucocerebrosidase Mutations in Primary Parkinsonism","volume":"20","author":"Asselta","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase Mutations Influence the Natural History of Parkinson\u2019s Disease in a Community-Based Incident Cohort","volume":"136","author":"Evans","year":"2013","journal-title":"Brain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.26477","article-title":"Autophagy and \u03b1-Synuclein: Relevance to Parkinson\u2019s Disease and Related Synucleopathies","volume":"31","author":"Xilouri","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Koros, C., Bougea, A., Simitsi, A.M., Papagiannakis, N., Angelopoulou, E., Pachi, I., Antonelou, R., Bozi, M., Stamelou, M., and Stefanis, L. (2023). The Landscape of Monogenic Parkinson\u2019s Disease in Populations of Non-European Ancestry: A Narrative Review. Genes, 14.","DOI":"10.3390\/genes14112097"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.26905","article-title":"Towards a Global View of Parkinson\u2019s Disease Genetics","volume":"95","author":"Khani","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.irn.2017.01.009","article-title":"Genetics of Parkinson\u2019s Disease: Genotype\u2013Phenotype Correlations","volume":"Volume 132","author":"Koros","year":"2017","journal-title":"International Review of Neurobiology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jia, F., Fellner, A., and Kumar, K.R. (2022). Monogenic Parkinson\u2019s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing. Genes, 13.","DOI":"10.3390\/genes13030471"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00702-024-02833-8","article-title":"Non-Motor Symptoms of Parkinson`s Disease-Insights from Genetics","volume":"131","year":"2024","journal-title":"J. Neural Transm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype-Phenotype Correlations between GBA Mutations and Parkinson Disease Risk and Onset","volume":"70","author":"Giladi","year":"2008","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA Are Associated with Familial Parkinson Disease Susceptibility and Age at Onset","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2011.06.015","article-title":"\u03b2-Glucocerebrosidase Gene Mutations in Two Cohorts of Greek Patients with Sporadic Parkinson\u2019s Disease","volume":"104","author":"Moraitou","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.26071","article-title":"GBA-Associated Parkinson\u2019s Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study","volume":"30","author":"Brockmann","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"725.e1","DOI":"10.1016\/j.neurobiolaging.2013.08.012","article-title":"Clinical Profiles of Parkinson\u2019s Disease Associated with Common Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Genetic Variants in Chinese Individuals","volume":"35","author":"Wang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","article-title":"Cognitive Performance of GBA Mutation Carriers with Early-Onset PD: The CORE-PD Study","volume":"78","author":"Alcalay","year":"2012","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and Dementia in GBA-Associated Parkinson\u2019s Disease: The Mutation Matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awu143","article-title":"Visual Short-Term Memory Deficits Associated with GBA Mutation and Parkinson\u2019s Disease","volume":"137","author":"Zokaei","year":"2014","journal-title":"Brain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/j.neurobiolaging.2015.08.027","article-title":"Impact of Glucocerebrosidase Mutations on Motor and Nonmotor Complications in Parkinson\u2019s Disease","volume":"36","author":"Oeda","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-Associated PD Presents with Nonmotor Characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2016.08.059","article-title":"Neuropsychiatric Characteristics of GBA-Associated Parkinson Disease","volume":"370","author":"Swan","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential Effects of Severe vs Mild GBA Mutations on Parkinson Disease","volume":"84","author":"Amshalom","year":"2015","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation-Positive Cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.23046","article-title":"Gaucher Disease Ascertained through a Parkinson\u2019s Center: Imaging and Clinical Characterization","volume":"25","author":"Hagenah","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/acn3.228","article-title":"GBA Mutations Are Associated with Rapid Eye Movement Sleep Behavior Disorder","volume":"2","author":"Mirelman","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Riboldi, G.M., and Di Fonzo, A.B. (2019). GBA, Gaucher Disease, and Parkinson\u2019s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells, 8.","DOI":"10.3390\/cells8040364"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liu, X., Cheng, R., Verbitsky, M., Kisselev, S., Browne, A., Mejia-Sanatana, H., Louis, E.D., Cote, L.J., Andrews, H., and Waters, C. (2011). Genome-Wide Association Study Identifies Candidate Genes for Parkinson\u2019s Disease in an Ashkenazi Jewish Population. BMC Med. Genet., 12.","DOI":"10.1186\/1471-2350-12-104"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jamaneurol.2016.1593","article-title":"High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews","volume":"73","author":"Shiner","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-201295","article-title":"The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews","volume":"80","author":"Shiner","year":"2021","journal-title":"J. Alzheimers. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.12.014","article-title":"A \u201cDose\u201d Effect of Mutations in the GBA Gene on Parkinson\u2019s Disease Phenotype","volume":"36","author":"Thaler","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ymgme.2019.10.001","article-title":"Revisiting the Non-Gaucher-GBA-E326K Carrier State: Is It Sufficient to Increase Parkinson\u2019s Disease Risk?","volume":"128","author":"Goldstein","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.12.014","article-title":"Carriers of Both GBA and LRRK2 Mutations, Compared to Carriers of Either, in Parkinson\u2019s Disease: Risk Estimates and Genotype-Phenotype Correlations","volume":"62","author":"Yahalom","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmg.2018.05.005","article-title":"Increased Yield of Full GBA Sequencing in Ashkenazi Jews with Parkinson\u2019s Disease","volume":"62","author":"Ruskey","year":"2019","journal-title":"Eur. J. Med. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1093\/brain\/awae188","article-title":"Relevance of Genetic Testing in the Gene-Targeted Trial Era: The Rostock Parkinson\u2019s Disease Study","volume":"147","author":"Westenberger","year":"2024","journal-title":"Brain"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Cristina, T.P., Pablo, M., Teresa, P.M., Lydia, V.D., Irene, A.R., Araceli, A.C., Inmaculada, B.B., Marta, B.T., Dolores, B.R., and Jos\u00e9, C.A.M. (2020). A Genetic Analysis of a Spanish Population with Early Onset Parkinson\u2019s Disease. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238098"},{"key":"ref_42","first-page":"e1","article-title":"Analysis of the Genetic Variability in Parkinson\u2019s Disease from Southern Spain","volume":"37","author":"Mencacci","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/mds.28195","article-title":"GBA-Related Parkinson\u2019s Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort","volume":"35","author":"Petrucci","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Salemi, M., Lanza, G., Salluzzo, M.G., Schillaci, F.A., Di Blasi, F.D., Cordella, A., Caniglia, S., Lanuzza, B., Morreale, M., and Marano, P. (2023). A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson\u2019s Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123118"},{"key":"ref_45","unstructured":"Bonato, G., Antonini, A., Pistonesi, F., Campagnolo, M., Guerra, A., Biundo, R., Pilleri, M., Bertolin, C., Salviati, L., and Carecchio, M. (2014). Genetic Mutations in Parkinson\u2019s Disease: Screening of a Selected Population from North-Eastern Italy. Neurol. Sci., Online ahead of Print."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/ene.12315","article-title":"Genetic Assessment of Familial and Early-Onset Parkinson\u2019s Disease in a Greek Population","volume":"21","author":"Bozi","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JPD-171221","article-title":"Phenotypic Characteristics in GBA-Associated Parkinson\u2019s Disease: A Study in a Greek Population","volume":"8","author":"Simitsi","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2016.07.008","article-title":"Mutations in Glucocerebrosidase Are a Major Genetic Risk Factor for Parkinson\u2019s Disease and Increase Susceptibility to Dementia in a Flanders-Belgian Cohort","volume":"629","author":"Crosiers","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/mds.28112","article-title":"A Large-Scale Full GBA1 Gene Screening in Parkinson\u2019s Disease in the Netherlands","volume":"35","author":"Cullen","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp-2017-317348","article-title":"Features of GBA-Associated Parkinson\u2019s Disease at Presentation in the UK Tracking Parkinson\u2019s Study","volume":"89","author":"Malek","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"212.e5","DOI":"10.1016\/j.neurobiolaging.2016.04.022","article-title":"Strong Association between Glucocerebrosidase Mutations and Parkinson\u2019s Disease in Sweden","volume":"45","author":"Ran","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.parkreldis.2017.09.021","article-title":"Genetic Risk Factors in Finnish Patients with Parkinson\u2019s Disease","volume":"45","author":"Siitonen","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.parkreldis.2013.05.003","article-title":"Comprehensive LRRK2 and GBA Screening in Portuguese Patients with Parkinson\u2019s Disease: Identification of a New Family with the LRRK2 p.Arg1441His Mutation and Novel Missense Variants","volume":"19","author":"Zhang","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s10072-023-07213-w","article-title":"GBA-Associated Parkinson\u2019s Disease in Hungary: Clinical Features and Genetic Insights","volume":"45","author":"Kossev","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"267.e7","DOI":"10.1016\/j.neurobiolaging.2018.06.027","article-title":"Mutation Analysis of Parkinson\u2019s Disease Genes in a Russian Data Set","volume":"71","author":"Emelyanov","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/brain\/awae142","article-title":"Parkinson\u2019s Disease Variant Detection and Disclosure: PD GENEration, a North American Study","volume":"147","author":"Cook","year":"2024","journal-title":"Brain"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/00207454.2015.1023436","article-title":"Mutations in the Glucocerebrosidase Gene Are Common in Patients with Parkinson\u2019s Disease from Eastern Canada","volume":"126","author":"Han","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41531-023-00571-4","article-title":"Mutational Spectrum and Clinical Features of GBA1 Variants in a Chinese Cohort with Parkinson\u2019s Disease","volume":"9","author":"Zhou","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/jhg.2014.110","article-title":"Mutations in the Glucocerebrosidase Gene Are Responsible for Chinese Patients with Parkinson\u2019s Disease","volume":"60","author":"Yu","year":"2015","journal-title":"J. Hum. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/ene.15230","article-title":"Prevalence and Genotype-Phenotype Correlations of GBA-Related Parkinson Disease in a Large Chinese Cohort","volume":"29","author":"Ren","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awaa167","article-title":"The Role of Genetics in Parkinson\u2019s Disease: A Large Cohort Study in Chinese Mainland Population","volume":"143","author":"Zhao","year":"2020","journal-title":"Brain"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","article-title":"Mutations for Gaucher Disease Confer High Susceptibility to Parkinson Disease","volume":"66","author":"Mitsui","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2012.02.035","article-title":"Association of Mutations in the Glucocerebrosidase Gene with Parkinson Disease in a Korean Population","volume":"514","author":"Choi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00702-021-02421-0","article-title":"Glucocerebrosidase (GBA) Gene Variants in a Multi-Ethnic Asian Cohort with Parkinson\u2019s Disease: Mutational Spectrum and Clinical Features","volume":"129","author":"Lim","year":"2022","journal-title":"J. Neural Transm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1468-1331.2011.03362.x","article-title":"Contribution of Glucocerebrosidase Mutation in a Large Cohort of Sporadic Parkinson\u2019s Disease in Taiwan","volume":"18","author":"Huang","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.parkreldis.2014.06.007","article-title":"Glucocerebrosidase Mutations in Thai Patients with Parkinson\u2019s Disease","volume":"20","author":"Pulkes","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kukkle, P.L., Geetha, T.S., Chaudhary, R., Sathirapongsasuti, J.F., Goyal, V., Kandadai, R.M., Kumar, H., Borgohain, R., Mukherjee, A., and Oliver, M. (2022). Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson\u2019s Disease Patients from India. Adv. Biol., 6.","DOI":"10.1002\/adbi.202101326"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"135816","DOI":"10.1016\/j.neulet.2021.135816","article-title":"Identification of GBA Mutations among Neurodegenerative Disease Patients from Eastern India","volume":"751","author":"Biswas","year":"2021","journal-title":"Neurosci. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2020.07.014","article-title":"Novel and Reported Variants in Parkinson\u2019s Disease Genes Confer High Disease Burden among Indians","volume":"78","author":"Kumar","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4103\/0028-3886.246249","article-title":"Genetic Analysis of the Glucocerebrosidase Gene in South Indian Patients with Parkinson\u2019s Disease","volume":"66","author":"Yadav","year":"2018","journal-title":"Neurol. India"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/mds.29699","article-title":"Clinicogenetic Characterization of Patients with PD and Heterozygous GBA1 Variants in an Indian Cohort","volume":"39","author":"Kamath","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1002\/mgg3.1671","article-title":"A Glimpse of the Genetics of Young-Onset Parkinson\u2019s Disease in Central Asia","volume":"9","author":"Kaiyrzhanov","year":"2021","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/mds.29931","article-title":"Parkinson\u2019s Disease Gene Screening in Familial Cases from Central and South America","volume":"39","author":"Mehta","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.parkreldis.2019.01.030","article-title":"The Distribution and Risk Effect of GBA Variants in a Large Cohort of PD Patients from Colombia and Peru","volume":"63","author":"Moreno","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2010.08.083","article-title":"Mutational Analysis of GIGYF2, ATP13A2 and GBA Genes in Brazilian Patients with Early-Onset Parkinson\u2019s Disease","volume":"485","author":"Pestana","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2016.10.040","article-title":"Autosomal Dominant Parkinson\u2019s Disease: Incidence of Mutations in LRRK2, SNCA, VPS35 and GBA Genes in Brazil","volume":"635","author":"Abreu","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41531-022-00358-z","article-title":"Lack of Full Sequencing GBA1 Studies for Patients with Parkinson\u2019s Disease in Latin America","volume":"8","author":"Mata","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Nuytemans, K., Rajabli, F., Bussies, P.L., Celis, K., Scott, W.K., Singer, C., Luca, C.C., Vinuela, A., Pericak-Vance, M.A., and Vance, J.M. (2020). Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.573733"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.29614","article-title":"Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis","volume":"39","author":"Camargos","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/WNL.0b013e318207b01e","article-title":"Mutations in the Glucocerebrosidase Gene Confer a Risk for Parkinson Disease in North Africa","volume":"76","author":"Lesage","year":"2011","journal-title":"Neurology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2009.11.066","article-title":"Glucocerebrosidase Mutations Are Not a Common Risk Factor for Parkinson Disease in North Africa","volume":"477","author":"Nishioka","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"156.e11","DOI":"10.1016\/j.neurobiolaging.2019.12.011","article-title":"Screening of the Glucocerebrosidase (GBA) Gene in South Africans of African Ancestry with Parkinson\u2019s Disease","volume":"88","author":"Mahungu","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/mds.28803","article-title":"Screening of GBA Mutations in Nigerian Patients with Parkinson\u2019s Disease","volume":"36","author":"Milanowski","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(23)00283-1","article-title":"Identification of Genetic Risk Loci and Causal Insights Associated with Parkinson\u2019s Disease in African and African Admixed Populations: A Genome-Wide Association Study","volume":"22","author":"Rizig","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.29753","article-title":"GBA1 Rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson\u2019s Disease in Nigerians","volume":"39","author":"Ojo","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2019.11.022","article-title":"Nanopore Sequencing of the Glucocerebrosidase (GBA) Gene in a New Zealand Parkinson\u2019s Disease Cohort","volume":"70","author":"Graham","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/mds.106","article-title":"A Novel Parkinson\u2019s Disease Risk Variant, p. W378R, in the Gaucher\u2019s Disease GBA Gene","volume":"33","author":"Lubomski","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41531-023-00526-9","article-title":"Elucidating Causative Gene Variants in Hereditary Parkinson\u2019s Disease in the Global Parkinson\u2019s Genetics Program (GP2)","volume":"9","author":"Lange","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mds.29288","article-title":"Embracing Monogenic Parkinson\u2019s Disease: The MJFF Global Genetic PD Cohort","volume":"38","author":"Vollstedt","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/mds.27081","article-title":"LARGE-PD: Examining the Genetics of Parkinson\u2019s Disease in Latin America","volume":"32","author":"Zabetian","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(21)00100-9","article-title":"The International Parkinson Disease Genomics Consortium Africa","volume":"20","author":"Rizig","year":"2021","journal-title":"Lancet. Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rajan, R., Divya, K.P., Kandadai, R.M., Yadav, R., Satagopam, V.P., Madhusoodanan, U.K., Agarwal, P., Kumar, N., Ferreira, T., and Kumar, H. (2020). Genetic Architecture of Parkinson\u2019s Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson\u2019s Disease Research. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00524"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Bandres-Ciga, S., Diez-Fairen, M., Kim, J.J., and Singleton, A.B. (2020). Genetics of Parkinson\u2019s Disease: An Introspection of Its Journey towards Precision Medicine. Neurobiol. Dis., 137.","DOI":"10.1016\/j.nbd.2020.104782"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"105282","DOI":"10.1016\/j.parkreldis.2023.105282","article-title":"Analysis of Deep Brain Stimulation of the Subthalamic Nucleus (STN-DBS) in Patients with Monogenic PRKN and LRRK2 Forms of Parkinson\u2019s Disease","volume":"107","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3233\/JPD-212986","article-title":"A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies","volume":"12","author":"Salles","year":"2022","journal-title":"J. Parkinsons. Dis."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/12\/1605\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:52:45Z","timestamp":1760115165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/12\/1605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":95,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["genes15121605"],"URL":"https:\/\/doi.org\/10.3390\/genes15121605","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]}}}